{"doc_desc":{"title":"\u00c9tude cas-t\u00e9moins sur l'\u00e9valuation du risque de cancer du sein associ\u00e9 \u00e0 l'utilisation des diff\u00e9rentes insulines","idno":"FRESH-PEF9090-fr","producers":[{"name":"Lamiae GRIMALDI-BENSOUDA","affiliation":"L.A. SANTE EPIDEMIOLOGIE EVALUATION RECH"}]},"study_desc":{"title_statement":{"idno":"FRESH-PEF9090-fr","IDno":{"metadata_no":[{"agency":"PEF","code":"9090"},{"agency":"FReSH","code":"FRESH-PEF9090"}]},"title":"\u00c9tude cas-t\u00e9moins sur l'\u00e9valuation du risque de cancer du sein associ\u00e9 \u00e0 l'utilisation des diff\u00e9rentes insulines","alternate_title":"ISICA"},"study_authorization":{"agency":[{"name":"CNIL"}]},"authoring_entity":[{"type":"investigator","name":"Lucien;ABENHAIM","PILabo":"La-Ser","affiliationName":"L.A. SANTE EPIDEMIOLOGIE EVALUATION RECH","extlink":[{"title":"","uri":"","role":"pi id"},{"title":"IdRef","uri":"072306513","role":"pi id"},{"title":"SIREN","uri":"450195979","role":"organisation id"},{"title":"","uri":"","role":"labo id"}],"email":"","isContact":"Non"},{"type":"investigator","name":"Lamiae;GRIMALDI-BENSOUDA","PILabo":"La-Ser \/ C121-SC of Vie-Pharma fourth group; U657 Pharmacoepidemiology and Evaluation of the Impact of Health Products on the Population\u2014Pasteur Institute","affiliationName":"L.A. SANTE EPIDEMIOLOGIE EVALUATION RECH","extlink":[{"title":"ORCID","uri":"0000-0003-1952-5467","role":"pi id"},{"title":"IdRef","uri":"077296125","role":"pi id"},{"title":"SIREN","uri":"450195979","role":"organisation id"},{"title":"","uri":"","role":"labo id"}],"email":"lamiae.grimaldi@aphp.fr","isContact":"Oui"}],"oth_id":[{"name":""}],"production_statement":{"prod_place":"Portail Epid\u00e9miologie France (PEF)","producers":[{"name":"SANOFI (FRANCE)","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/02n6c9837","role":"sponsor id"},{"title":"SIREN","uri":"395030844","role":"sponsor id"}],"role":"sponsor"},{"name":"L.A. SANTE EPIDEMIOLOGIE EVALUATION RECH","extlink":[{"title":"SIREN","uri":"450195979","role":"sponsor id"}],"role":"sponsor"}],"funding_agencies":[{"name":"L.A. SANTE EPIDEMIOLOGIE EVALUATION RECH","extlink":[{"title":"SIREN","uri":"450195979"}]},{"name":"SANOFI (FRANCE)","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/02n6c9837"},{"title":"SIREN","uri":"395030844"}]}]},"distribution_statement":{"contact":[{"name":"Lamiae;GRIMALDI-BENSOUDA","email":"lamiae.grimaldi@aphp.fr","type":"contact","affiliationName":"L.A. SANTE EPIDEMIOLOGIE EVALUATION RECH","contactPointLabo":"","extlink":[{"uri":"450195979","role":"organisation id","title":"SIREN"}]}]},"study_info":{"keywords":[{"keyword":"Insuline"},{"keyword":"glargine"},{"keyword":"aspart"},{"keyword":"lispro"},{"keyword":"cancer"},{"keyword":"diab\u00e8te"},{"keyword":"traitement hormonal"},{"keyword":"contraception"}],"topics":[{"topic":"Oncologie","vocab":"health theme","extLink":[{"title":"ESV","uri":"http:\/\/data.europa.eu\/8mn\/euroscivoc\/5784b7f1-c7ce-49d9-9f38-aebcda0ff41d"},{"title":"MeSH","uri":"http:\/\/id.nlm.nih.gov\/mesh\/D008495"}]},{"topic":"Endocrinologie","vocab":"health theme","extLink":[{"title":"ESV","uri":"http:\/\/data.europa.eu\/8mn\/euroscivoc\/d1dd1bac-5313-4ab3-837f-4acd3ec521a7"},{"title":"MeSH","uri":"http:\/\/id.nlm.nih.gov\/mesh\/D004704"}]},{"topic":"Gyn\u00e9cologie et obst\u00e9trique","vocab":"health theme","extLink":[{"title":"ESV","uri":"http:\/\/data.europa.eu\/8mn\/euroscivoc\/7de64596-5b0d-4977-8f98-b982ff2ec17d"},{"title":"ESV","uri":"http:\/\/data.europa.eu\/8mn\/euroscivoc\/284ca20c-beb4-4abe-99fa-ef4513358bad"},{"title":"MeSH","uri":"http:\/\/id.nlm.nih.gov\/mesh\/D006176"},{"title":"MeSH","uri":"http:\/\/id.nlm.nih.gov\/mesh\/D009774"}]},{"topic":"Tumeurs malignes du sein","vocab":"cim-11","extLink":[{"uri":"http:\/\/id.who.int\/icd\/entity\/1047754165","title":"CIM-11"}]},{"topic":"Diab\u00e8te sucr\u00e9, type non pr\u00e9cis\u00e9","vocab":"cim-11","extLink":[{"uri":"http:\/\/id.who.int\/icd\/entity\/1697306310","title":"CIM-11"}]},{"topic":"D\u00e9terminants li\u00e9s au syst\u00e8me de sant\u00e9 : Consommation des soins","vocab":"health determinant"},{"topic":"D\u00e9terminants li\u00e9s au syst\u00e8me de sant\u00e9","vocab":"health determinant"}],"purpose":"L'objectif est d'\u00e9tudier l'utilisation de diff\u00e9rentes insuline (dur\u00e9e de l'exposition, doses administr\u00e9es) et son possible lien avec l'augmentation du risque de cancer du sein.","abstract":"","coll_dates":[{"start":"2008-01-01","end":"2009-01-01"}],"nation":[{"name":"France","abbreviation":"fr","extLink":{"vocab":"ISO","vocabURI":"fr"}},{"name":"Canada","abbreviation":"ca","extLink":{"vocab":"ISO","vocabURI":"ca"}},{"name":"Royaume-Uni","abbreviation":"gb","extLink":{"vocab":"ISO","vocabURI":"gb"}}],"geog_coverage":"","analysis_unit":"Individus","universe":"{\n    \"level_sex_clusion_I\": [\n        {\n            \"value\": \"F\u00e9minin\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D005260\"\n            }\n        }\n    ],\n    \"level_age_clusion_I\": [\n        {\n            \"value\": \"Adulte (19 \u00e0 24 ans)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D055815\"\n            }\n        },\n        {\n            \"value\": \"Adulte (25 \u00e0 44 ans)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D000328\"\n            }\n        },\n        {\n            \"value\": \"Adulte (45 \u00e0 64 ans)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D008875\"\n            }\n        },\n        {\n            \"value\": \"Personne \u00e2g\u00e9e (65 \u00e0 79 ans)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D000368\"\n            }\n        }\n    ],\n    \"level_type_clusion_I\": \"Patients\",\n    \"level_type_clusion_other\": \"\",\n    \"clusion_I\": \"Pour les cas :  - Diagnostic de cancer du sein entre le 1er janvier 2008 et le 30 juin 2009 - Diab\u00e8te confirm\u00e9 par le patient et les dossiers d'anesth\u00e9sie  Pour les t\u00e9moins : - Absence de cancer du sein - Diab\u00e8te confirm\u00e9 par le patient et les dossiers d'anesth\u00e9sie\",\n    \"clusion_E\": \"\"\n}","data_kind":"['Donn\u00e9es cliniques','Donn\u00e9es rapport\u00e9es par le participant de l'\u00e9tude','Donn\u00e9es paracliniques','Donn\u00e9es biologiques']","quality_statement":{"standards":[{"name":"","committee":"","governance":""}],"other_quality_statement":""}},"study_development":{"development_activity":[{"activity_type":"primary evaluation","activity_description":"Ev\u00e9nements de sant\u00e9\/morbidit\u00e9\r\nConsommation de soins\/services de sant\u00e9"}]},"method":{"data_collection":{"time_method":"","frequency":"","sampling_procedure":"['{\"concept\":{\"vocabURI\":\"Other\",\"vocab\":\"CESSDA\"},\"value\":\"Autre\"}']","sample_frame":{"frame_unit":{"unit_type":"['Via des structures (services ou \u00e9tablissements de sant\u00e9, \u00e9coles, entreprises\u2026)']"}},"coll_mode":["{\"concept\":{\"vocabURI\":\"Transcription\",\"vocab\":\"CESSDA\"},\"value\":\"Transcription et saisie d\u2019informations dans un enregistrement structur\u00e9\"}","{\"concept\":{\"vocabURI\":\"Interview\",\"vocab\":\"CESSDA\"},\"value\":\"Entretien avec le participant (dont clinique)\"}"],"research_instrument":"Acc\u00e8s restreint sur projet sp\u00e9cifique","sources":[],"target_sample_size":"[1000-10000[ individus","response_rate":"3825"},"method_notes":"Etude observationnelle","study_class":"\u00c9tude compl\u00e9t\u00e9e","notes":[{"subject":"research type","values":["Etude observationnelle"]},{"subject":"observational study method","values":["Etude cas-t\u00e9moins"]}]},"data_access":{"dataset_availability":{"access_place":"","complete":"","status":"{\"value\":\"Acc\u00e8s r\u00e9serv\u00e9\",\"extLink\":[{\"title\":\"COAR\",\"uri\":\"http:\/\/purl.org\/coar\/access_right\/c_16ec\"}]}"},"dataset_use":{"restrictions":"","conditions":"Contacter le responsable scientifique","conf_dec":[{"txt":""}],"spec_perm":[{"txt":"","required":""}],"contact":[{"name":""}],"deposit_req":"","cit_req":""},"notes":""}},"additional":{"IsImport":true,"versionLang":"fr","originLang":"fr","autoTranslation":false,"status":"imported","creationDate":"10-06-2014","lastUpdatedAuto":null,"lastUpdatedManual":"01-01-2019","isContributorPI":"Non","contributorName":"Lamiae GRIMALDI-BENSOUDA","contributorAffiliation":"L.A. SANTE EPIDEMIOLOGIE EVALUATION RECH","addTeamMember":"","obtainedAuthorization":{"otherAuthorizingAgency":[""]},"relatedDocument":[{"type":"","title":"","link":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23949559"}],"regulatoryRequirements":{"conformityDeclaration":""},"fundingAgent":{"fundingAgentType":["Industrie","Industrie"],"otherFundingAgentType":["",""]},"sponsor":{"sponsorType":["Industrie","Industrie"],"otherSponsorType":["",""]},"governance":{"committee":""},"collaborations":{"networkConsortium":""},"theme":{"complementaryInformation":"","RareDiseases":""},"activeFollowUp":{"isActiveFollowUp":"Non","followUpModeOther":""},"interventionalStudy":{"researchPurpose":[],"trialPhase":[],"interventionalStudyModel":"","isClinicalTrial":"","otherResearchPurpose":""},"isInclusionGroups":"","allocation":{"allocationMode":"","allocationUnit":""},"masking":{"maskingType":"","blindedMaskingDetails":[]},"arms":[],"intervention":[],"inclusionGroups":[],"collectionProcess":{"collectionModeDetails":"","collectionModeOther":""},"dataCollection":{"inclusionStrategyOther":"","samplingModeOther":"","recruitmentSourceOther":"","otherDocumentation":""},"dataCollectionIntegration":{"isDataIntegration":"Non"},"geographicalCoverage":{"geoDetail":"France, Canada, Royaume-Uni"},"dataTypes":{"clinicalDataDetails":"Histoire du diab\u00e8te, facteurs de risque, prescriptions, donn\u00e9es d\u00e9taill\u00e9es sur le diab\u00e8te (de type, l'\u00e2ge au moment du diagnostic, la dur\u00e9e, traitements), les complications (r\u00e9nales, vasculaires, ophtalmologiques et neurologiques) , Informations concernant l'histoire du Cancer du sein et de l'ovaire, insulinoth\u00e9rapie (glargine, aspart, lispro et insuline humaine), traitement hormonal substitutif, maternit\u00e9, premi\u00e8res r\u00e8gles, m\u00e9nopause, allaitement, contraception orale. Exposition \u00e0 l'insuline","biologicalDataDetails":"HbA1c,","isDataInBiobank":"Non","biobankContent":[],"biobankContentOther":"","dataTypeOther":""},"variableDictionnary":{"variableDictionnaryAvailable":"","variableDictionnaryLink":""},"dataQuality":{"otherDocumentation":""},"mockSample":{"mockSampleAvailable":"","mockSampleLocation":""},"thirdPartySource":{"otherSourceType":[]},"isHealthTheme":"Oui","fileDscr":{"fileTxt":{"fileCitation":{"titlStmt":{"IDno":[]}}}}},"schematype":"survey"}